UBS Initiates Coverage On enGene Holdings with Buy Rating, Announces Price Target of $37
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Colin Bristow initiates coverage on enGene Holdings (NASDAQ:ENGN) with a Buy rating and a price target of $37.

March 28, 2024 | 3:06 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UBS initiated coverage on enGene Holdings with a Buy rating and set a price target of $37.
The initiation of coverage by a major financial institution like UBS, especially with a Buy rating and a significant price target, is likely to generate positive sentiment among investors. This could lead to increased demand for ENGN shares in the short term, potentially driving up the stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100